Loading...
•
Dec 31, 2025
HCA Q4 2025 Earnings Report
HCA Healthcare reported strong financial and operating results for the fourth quarter ended December 31, 2025.
Key Takeaways
HCA Healthcare announced a robust fourth quarter for 2025, with revenues increasing by 6.7% to $19.513 billion and net income attributable to HCA Healthcare, Inc. surging by 30.6% to $1.878 billion. Diluted earnings per share rose significantly by 44.6% to $8.14, while Adjusted EBITDA increased by 10.8% to $4.114 billion, reflecting strong performance consistent with previous quarters.
Revenues increased 6.7 percent to $19.513 billion in Q4 2025 compared to Q4 2024.
Net income attributable to HCA Healthcare, Inc. increased 30.6 percent to $1.878 billion in Q4 2025.
Diluted earnings per share increased 44.6 percent to $8.14 per share in Q4 2025.
Adjusted EBITDA increased 10.8 percent to $4.114 billion in Q4 2025.
Forward Guidance
HCA Healthcare provided estimated guidance for 2026, projecting revenues between $76.500 billion and $80.000 billion, and diluted EPS between $29.10 and $31.50 per share. The guidance assumes stable operating environment and volume growth, but excludes impacts from potential future events like facility sales or debt retirements.
Positive Outlook
- Projected revenue growth with a range of $76.500 billion to $80.000 billion.
- Anticipated diluted EPS between $29.10 and $31.50 per share.
- Expected Adjusted EBITDA between $15.550 billion and $16.450 billion.
- Guidance assumes an anticipated mostly stable operating environment.
- Guidance includes current expectations regarding volume growth.
Challenges Ahead
- Excludes potential gains or losses on sales of facilities.
- Excludes losses on retirement of debt.
- Excludes legal claims costs (benefits) and impairments of long-lived assets.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...